All Phenotypes Pole<tm1.1Bdp> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
hm1	Pole^tm1.1Bdp/Pole^tm1.1Bdp	B6.129-Pole^tm1.1Bdp	MGI:4366918
hm2	Pole^tm1.1Bdp/Pole^tm1.1Bdp	involves: 129S1/Sv * 129X1/SvJ * C57BL/6J	MGI:4366919
cx3	Pold1^tm1.1Bdp/Pold1^tm1.1Bdp Pole^tm1.1Bdp/Pole^tm1.1Bdp	B6.129-Pole^tm1.1Bdp Pold1^tm1.1Bdp	MGI:4366922
cx4	Mlh1^tm1Rak/Mlh1^tm1Rak Pole^tm1.1Bdp/Pole^tm1.1Bdp	involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J	MGI:4366924
cx5	Msh2^tm1Rak/Msh2^tm1Rak Pole^tm1.1Bdp/Pole^tm1.1Bdp	involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J	MGI:4366925

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:153684 )

• between 9 and 24 months mice succumb to cancer; median survival is 16 months

neoplasm

increased intestinal adenocarcinoma incidence ( J:153684 )

• 45% of mice develop intestinal adenomas and adenocarcinomas compared with 5% of wild-type mice

increased colon adenocarcinoma incidence ( J:153684 )

• in one mouse

increased small intestine adenocarcinoma incidence ( J:153684 )

• in 13 of 15 mice with no evidence of metastasis

increased adenoma incidence ( J:153684 )

• one mouse developed a gastric adenoma

increased intestinal adenoma incidence ( J:153684 )

• 45% of mice develop intestinal adenomas and adenocarcinomas compared with 5% of wild-type mice

increased lymphoma incidence ( J:153684 )

• 24% of mice develop nodal lymphomas compared with 6% of wild-type mice

increased histiocytic sarcoma incidence ( J:153684 )

• in 36% of mice compared with 22% of wild-type mice

increased lung tumor incidence ( J:153684 )

• 12% of mice develop lung adenomas and adenocarcinomas compared with 9% of wild-type mice

immune system

enlarged spleen ( J:153684 )

• in mice some mice

hematopoietic system

enlarged spleen ( J:153684 )

• in mice some mice

digestive/alimentary system

increased intestinal adenocarcinoma incidence ( J:153684 )

• 45% of mice develop intestinal adenomas and adenocarcinomas compared with 5% of wild-type mice

increased colon adenocarcinoma incidence ( J:153684 )

• in one mouse

increased small intestine adenocarcinoma incidence ( J:153684 )

• in 13 of 15 mice with no evidence of metastasis

increased intestinal adenoma incidence ( J:153684 )

• 45% of mice develop intestinal adenomas and adenocarcinomas compared with 5% of wild-type mice

growth/size/body

enlarged spleen ( J:153684 )

• in mice some mice

respiratory system

increased lung tumor incidence ( J:153684 )

• 12% of mice develop lung adenomas and adenocarcinomas compared with 9% of wild-type mice

Allelic Composition	Pole^tm1.1Bdp/Pole^tm1.1Bdp
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * C57BL/6J

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pole^tm1.1Bdp mutation (0 available); any Pole mutation (99 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:153684 )

neoplasm

increased tumor incidence ( J:153684 )

Allelic Composition	Pold1^tm1.1Bdp/Pold1^tm1.1Bdp Pole^tm1.1Bdp/Pole^tm1.1Bdp
Genetic Background	B6.129-Pole^tm1.1Bdp Pold1^tm1.1Bdp

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pold1^tm1.1Bdp mutation (0 available); any Pold1 mutation (62 available)
Pole^tm1.1Bdp mutation (0 available); any Pole mutation (99 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:153684 )

• mice die before 6 months

neoplasm

increased T cell derived lymphoma incidence ( J:153684 )

• in 82% of mice unlike in wild-type mice

increased skin tumor incidence ( J:153684 )

• 6% of mice develop tail skin squamous cell neoplasms (papilloma or carcinoma) unlike wild-type mice

integument

increased skin tumor incidence ( J:153684 )

• 6% of mice develop tail skin squamous cell neoplasms (papilloma or carcinoma) unlike wild-type mice

endocrine/exocrine glands

increased T cell derived lymphoma incidence ( J:153684 )

• in 82% of mice unlike in wild-type mice

Allelic Composition	Mlh1^tm1Rak/Mlh1^tm1Rak Pole^tm1.1Bdp/Pole^tm1.1Bdp
Genetic Background	involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mlh1^tm1Rak mutation (1 available); any Mlh1 mutation (42 available)
Pole^tm1.1Bdp mutation (0 available); any Pole mutation (99 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

lethality during fetal growth through weaning, complete penetrance ( J:153684 )

• mice are present in normal ratios up to E14.5; none are recovered at weaning

Allelic Composition	Msh2^tm1Rak/Msh2^tm1Rak Pole^tm1.1Bdp/Pole^tm1.1Bdp
Genetic Background	involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Msh2^tm1Rak mutation (1 available); any Msh2 mutation (95 available)
Pole^tm1.1Bdp mutation (0 available); any Pole mutation (99 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

postnatal lethality, complete penetrance ( J:153684 )

• no mice are present at weaning

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/23/2024 MGI 6.23